Armistice Capital Joins Vanguard, BlackRock in Major PTC Therapeutics Stakes During Key Pipeline Milestones
Three major institutional investors maintain substantial positions in PTC Therapeutics as the company navigates regulatory approvals and setbacks across its rare disease portfolio.…
